Yasuhiro Mitsuuchi
Impact in
-
- Hormonal Regulation and Hypertension
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cell death mechanisms and regulation 7
- PI3K/AKT/mTOR signaling in cancer 7
- Metabolism, Diabetes, and Cancer 5
- Oncology 10
- Cancer-related Molecular Pathways 5
- PARP inhibition in cancer therapy 5
- Co-authors
- Joseph R. Testa (11 shared papers)Takeshi Kawamoto (11 shared papers)Katsumi Toda (10 shared papers)Steven W. Johnson (5 shared papers)Michael Jeffers (1 shared paper)Guang‐Hui Xiao (1 shared paper)Alfonso Bellacosa (1 shared paper)George F. Vande Woude (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Oncogene (4 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Yasuhiro Mitsuuchi
38 papers receiving 2.9k citations
Yasuhiro Mitsuuchi's Hit Papers
Peers
Comparison fields: 5 of 107
- Endocrinology, Diabetes and Metabolism 637
- Pharmacology 255
- Molecular Biology 1.9k
- Hepatology 182
- Immunology 468
Countries citing papers authored by Yasuhiro Mitsuuchi
This map shows the geographic impact of Yasuhiro Mitsuuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Mitsuuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Mitsuuchi more than expected).
Fields of papers citing papers by Yasuhiro Mitsuuchi
This network shows the impact of papers produced by Yasuhiro Mitsuuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Mitsuuchi. The network helps show where Yasuhiro Mitsuuchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yasuhiro Mitsuuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL Hit paper breakdown → | 2015 | 529 |
| 2 | 2000 | 361 | |
| 3 | 2003 | 224 | |
| 4 | 1992 | 214 | |
| 5 | 1999 | 197 | |
| 6 | 1999 | 175 | |
| 7 | 1990 | 142 | |
| 8 | The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. | 2000 | 125 |
| 9 | 1990 | 120 | |
| 10 | 1998 | 117 | |
| 11 | 1987 | 117 | |
| 12 | 1990 | 88 | |
| 13 | 2013 | 84 | |
| 14 | 1993 | 78 | |
| 15 | 2004 | 72 | |
| 16 | 1989 | 52 | |
| 17 | 2002 | 49 | |
| 18 | 1992 | 46 | |
| 19 | 1992 | 35 | |
| 20 | 1993 | 35 |
About Yasuhiro Mitsuuchi
Yasuhiro Mitsuuchi is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Immunology and Pharmacology, having authored 38 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (8 papers), Cell death mechanisms and regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Metabolism, Diabetes, and Cancer (5 papers), Cancer-related Molecular Pathways (5 papers), PARP inhibition in cancer therapy (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Hormonal and reproductive studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (637 citations), Pharmacology (255 citations), Molecular Biology (1.9k citations), Hepatology (182 citations) and Immunology (468 citations). Yasuhiro Mitsuuchi has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Joseph R. Testa, Takeshi Kawamoto, Katsumi Toda, Steven W. Johnson, Michael Jeffers, Guang‐Hui Xiao, Alfonso Bellacosa, George F. Vande Woude, Yuichi Yokoyama and Yutaka Shizuta. Their work appears in journals such as Biochemical and Biophysical Research Communications, Oncogene, Cancer Research, Molecular Cancer Therapeutics and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.